A Novel Skeleton Transformation of 2a-Substituted 2a,8b-Dihydro-3H-benzo[b]cyclobuta[d]pyran-3-ones to 2-(2-Oxoethyl)-2H-1-benzopyrans Promoted by a Combination of ZnI2, Organic Base and H2O

Navnath Dnyanoba Yadav; Masayuki Yamashita; Yumiko Saya; Ai Kurume; Ikuo Kawasaki; Shunsaku Ohta

doi:10.1055/s-2008-1032044

LETTER

A Novel Skeleton Transformation of 2a-Substituted 2a,8b-Dihydro-3H-benzo[b]cyclobuta[d]pyran-3-ones to 2-(2-Oxoethyl)-2H-1-benzopyrans Promoted by a Combination of ZnI₂, Organic Base and H₂O

Navnath Dnyanoba Yadav^a, Masayuki Yamashita*^a, Yumiko Saya^a, Ai Kurume^a, Ikuo Kawasaki^a,b, Shunsaku Ohta^a
^a Department of Functional Molecular Chemistry, 21st COE Program, Kyoto Pharmaceutical University, Misasagi-Nakauchi, Yamashina, Kyoto 607-8414, Japan
Fax: +81(75)5954795; e-Mail: yamasita@mb.kyoto-phu.ac.jp;
^b School of Pharmaceutical Sciences, Mukogawa Women’s University, Koshien Kyuban-cho, Nishinomiya 663-8179, Japan

Abstract

All articles of this category

Abstract

The novel skeleton transformation reaction of 2a-substituted 2a,8b-dihydrobenzo[b]cyclobuta[d]pyran-3-one derivatives into 2-(2-substituted 2-oxoethyl)-2H-1-benzopyran derivatives has been accomplished using Znl₂ in the presence of an organic base and water in excellent yields.

Key words

heterocycles - Lewis acids - photochemistry - rearrangements - ring opening

Full Text

References

References and Notes

Recent reviews:

1a Dolbier WR. Battiste MA. Chem. Rev. 2003, 103: 1071

1b Fedoryński M. Chem. Rev. 2003, 103: 1099

1c Sydnes LK. Chem. Rev. 2003, 103: 1133

1d Reissig H.-U. Zimmer R. Chem. Rev. 2003, 103: 1151

1e Baldwin JE. Chem. Rev. 2003, 103: 1197

1f Brandi A. Cicchi S. Cordero FM. Goti A. Chem. Rev. 2003, 103: 1213

1g Baird M. Chem. Rev. 2003, 103: 1271

1h Nakamura M. Isobe H. Nakamura E. Chem. Rev. 2003, 103: 1295

1i Lee-Ruff E. Mladenova G. Chem. Rev. 2003, 103: 1449

1j Namyslo JC. Kaufmann DE. Chem. Rev. 2003, 103: 1485

1k Donaldson WA. Tetrahedron 2001, 57: 8589

1l Sydnes LK. Eur. J. Org. Chem. 2000, 3511

1m Iwasawa N. Narasaka K. Top. Curr. Chem. 2000, 207: 69

1n de Meijere A. Kozhushkov SI. Khlebnikov AF. Top. Curr. Chem. 2000, 207: 89

1o de Meijere A. Kozhushkov SI. Hadjiarapoglou LP. Top. Curr. Chem. 2000, 207: 149

1p Nemoto H. Fukumoto K. Synlett 1997, 863

1q Brandi A. Cordero FM. De Sarlo F. Goti A. Guarna A. Synlett 1993, 1

2a Yamashita M. Okuyama K. Kawajiri T. Takada A. Inagaki Y. Nakano H. Tomiyama M. Ohnaka A. Terayama I. Kawasaki I. Ohta S. Tetrahedron 2002, 58: 1497

2b Yamashita M. Okuyama K. Ohhara T. Kawasaki I. Michihiro Y. Sakamaki K. Ito S. Ohta S. Chem. Pharm. Bull. 1999, 47: 1439

2c Yamashita M. Okuyama K. Ohhara T. Kawasaki I. Ohta S. Synlett 1996, 547

2d Yamashita M. Okuyama K. Ohhara T. Kawasaki I. Sakai K. Nakata S. Kawabe T. Kusumoto M. Ohta S. Chem. Pharm. Bull. 1995, 43: 2075

2e Yamashita M. Okuyama K. Kawasaki I. Ohta S. Tetrahedron Lett. 1995, 36: 5603

2f Yamashita M. Okuyama K. Ohhara T. Kawasaki I. Ohta S. Chem. Pharm. Bull. 1995, 43: 708

3a Yamashita M. Inaba T. Nagahama M. Shimizu T. Kosaka S. Kawasaki I. Ohta S. Org. Biomol. Chem. 2005, 3: 2296

3b Yamashita M. Inaba T. Shimizu T. Kawasaki I. Ohta S. Synlett 2004, 1897

4 Mimaki Y. Kameyama A. Sashida Y. Miyata Y. Fujii A. Chem. Pharm. Bull. 1995, 43: 893

5 Orjala J. Wright AD. Erdelmeier CAJ. Sticher O. Rali T. Helv. Chim. Acta 1993, 76: 1481

6a Yamashita M. Yadav ND. Sawaki T. Takao I. Kawasaki I. Sugimoto Y. Miyatake A. Murai K. Takahara A. Kurume A. Ohta S. J. Org. Chem. 2007, 72: 5697

6b Yamashita M. Yadav ND. Sumida Y. Kawasaki I. Kurume A. Ohta S. Tetrahedron Lett. 2007, 48: 5619

6c Yamashita M. Shimizu T. Inaba T. Takada A. Takao I. Kawasaki I. Ohta S. Heterocycles 2005, 65: 1099

6d Yamashita M. Ohta N. Shimizu T. Matsumoto K. Matsuura Y. Kawasaki I. Tanaka T. Maezaki N. Ohta S. J. Org. Chem. 2003, 68: 1216

6e Yamashita M. Ohta N. Kawasaki I. Ohta S. Org. Lett. 2001, 3: 1359

For example:

7a Merlini L. In Advances in Heterocyclic Chemistry Vol. 18: Katritzky AR. Boulton AJ. Academic Press; New York: 1975. p.159

7b Ellis GP. Lockhart IM. In The Chemistry of Heterocyclic Compounds: Chromans and Tocopherols Vol. 31: John Wiley & Sons; New York: 1981. p.1

7c Ellis GP. The Chemistry of Heterocyclic Compound: Chromenes, Chromanones, and Chromones Vol. 31: John Wiley & Sons; New York: 1977. p.1

7d Brogden PJ. Gabbutt CD. Hepworth JD. In Comprehensive Heterocyclic Chemistry Vol. 3: Katritzky AR. Rees CW. Boulton AJ. McKillop A. Pergamon Press; Oxford: 1984. p.574

7e Ellis GP. In Comprehensive Heterocyclic Chemistry Vol. 3: Katritzky AR. Rees CW. Boulton AJ. McKillop A. Pergamon Press; Oxford: 1984. p.647

7f Hepworth JD. In Comprehensive Heterocyclic Chemistry Vol. 3: Katritzky AR. Rees CW. Boulton AJ. McKillop A. Pergamon Press; Oxford: 1984. p.737

For example:

8a Kanadaswami C. Lee L.-T. Lee P.-PH. Hwang J.-J. Ke F.-C. Huang Y.-T. Lee M.-T. In Vivo 2005, 19: 895

8b Tanaka T. Higa S. Hirano T. Arimitsu J. Naka T. Shima Y. Ohshima S. Fujimoto M. Yamadori T. Kawase I. Recent Res. Dev. Allergy Clin. Immunol. 2004, 5: 1

8c Haraguchi H. In Bioactive Compounds from Natural Sources Tringali C. Taylor & Francis Ltd.; London: 2001. p.337

8d Ishikawa T. Heterocycles 2000, 53: 453

9a Yamashita M. Yadav ND. Nagahama M. Inaba T. Nishino Y. Miura K. Kosaka S. Fukao J. Kawasaki I. Ohta S. Heterocycles 2005, 65: 2411

9b Schwebel D. Margaretha P. Helv. Chim. Acta 2000, 83: 1168

10

The cyclobutabenzopyrans 3 were relatively stable under these conditions except for 3a.

11

General Procedure: ZnI₂ (0.142 mmol) and piperidine (0.426 mmol) were added to a solution of 2a-substituted 2a,8b-dihydrobenzo[b]cyclobuta[d]pyran-3-one 3 (0.142 mmol) in THF-H₂O (3 mL:0.1 mL) at r.t., and the whole was refluxed. After disappearance of 3 was checked by TLC, the reaction mixture was acidified with 10% HCl. The mixture was extracted with EtOAc (3 × 15 mL). The combined extracts were washed, dried, and evaporated. The residue was chromatographed to give 2-(2-substituted 2-oxoethyl)-2H-1-benzopyran 6.¹²

12

5-Methoxy-2-(2-oxopropyl)-3-phenyl-2 H -1-benzopyran (6a): yellowish oil. ¹H NMR (300 MHz, CDCl₃): δ = 2.15 (s, 3 H), 2.34 (dd, J = 2.2, 15.9 Hz, 1 H), 3.10 (dd, J = 10.2, 15.9 Hz, 1 H), 3.84 (s, 3 H), 5.89 (dd, J = 2.3, 10.2 Hz, 1 H), 6.49 (d, J = 8.1 Hz, 1 H), 6.51 (d, J = 8.1 Hz, 1 H), 7.09 (t, J = 8.3 Hz, 1 H), 7.19 (s, 1 H), 7.24-7.39 (m, 3 H), 7.49-7.53 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 31.0, 45.6, 55.6, 72.1, 103.7, 109.5, 111.8, 114.5, 125.1, 127.9, 128.8, 129.4, 132.3, 136.2, 151.4, 155.6, 206.1. IR (CHCl₃): 1708, 1594 cm^-1. MS: m/z (%) = 294 (20.3) [M⁺], 237 (100). HRMS: m/z [M⁺] calcd for C₁₉H₁₈O₃: 294.1256; found: 294.1257.3-Phenyl-2-(2-phenyl-2-oxoethyl)-2 H -1-benzopyran (6b): colorless crystals (recrystallized from EtOAc); mp 136-138 °C. ¹H NMR (300 MHz, CDCl₃): δ = 2.78 (dd, J = 2.2, 16.5 Hz, 1 H), 3.80 (dd, J = 9.6, 16.4 Hz, 1 H), 6.20 (dd, J = 2.2, 9.7 Hz, 1 H), 6.72 (d, J = 7.9 Hz, 1 H), 6.88 (s, 1 H), 6.93 (td, J = 1.1, 7.4 Hz, 1 H), 7.09 (dd, J = 1.7, 7.8 Hz, 1 H), 7.13 (td, J = 1.5, 7.2 Hz, 1 H), 7.29-7.42 (m, 5 H), 7.50-7.58 (m, 3 H), 7.82-7.86 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 41.1, 72.7, 116.9, 120.0, 121.8, 122.5, 125.4, 127.0, 128.2, 128.3, 128.5, 128.9, 129.4, 133.2, 134.7, 136.1, 137.0, 151.0, 197.2. IR (CHCl₃): 1677, 1594 cm^-1. MS: m/z (%) = 326 (5.8) [M⁺], 207 (100), 178 (11.5). HRMS: m/z [M⁺] calcd for C₂₃H₁₈O₂: 326.1307; found: 326.1303. Anal. Calcd for C₂₃H₁₈O₂: C, 84.64; H, 5.56. Found: C, 84.51; H, 5.57.Methyl (3-Phenyl-2 H -1-benzopyran-2-yl)acetate (6c): colorless needles (recrystallized from EtOAc-n-hexane); mp 182-183 °C. ¹H NMR (300 MHz, CDCl₃): δ = 2.46 (dd, J = 2.9, 15.2 Hz, 1 H), 2.87 (dd, J = 9.9, 15.2 Hz, 1 H), 3.66 (s, 3 H), 5.89 (dd, J = 2.9, 10.1 Hz, 1 H), 6.82 (s, 1 H), 6.87 (d, J = 8.1 Hz, 1 H), 6.93 (td, J = 1.1, 7.4 Hz, 1 H), 7.11 (dd, J = 1.7, 7.5 Hz, 1 H), 7.16 (td, J = 1.7, 7.7 Hz, 1 H), 7.28-7.35 (m, 1 H), 7.36-7.42 (m, 2 H), 7.49-7.54 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 38.1, 51.8, 73.0, 116.7, 120.2, 121.8, 122.2, 125.3, 127.0, 128.2, 128.9, 129.5, 134.1, 136.1, 150.8, 170.8. IR (CHCl₃): 1725, 1612 cm^-1. MS: m/z (%) = 280 (8.8) [M⁺], 207 (100), 178 (12.6). HRMS: m/z [M⁺] calcd for C₁₈H₁₆O₃: 280.1099; found: 280.1101. Anal. Calcd for C₁₈H₁₆O₃: C, 77.12; H, 5.75. Found: C, 76.50; H, 5.98.3-Butyl-2-(2-phenyl-2-oxoethyl)-2 H -1-benzopyran (6d): yellowish oil. ¹H NMR (300 MHz, CDCl₃): δ = 0.94 (t, J = 7.2 Hz, 3 H), 1.30-1.45 (m, 2 H), 1.45-1.65 (m, 2 H), 2.13 (t, J = 7.8 Hz, 2 H), 2.83 (dd, J = 3.1, 15.8 Hz, 1 H), 3.64 (dd, J = 9.0, 15.8 Hz, 1 H), 5.40 (dd, J = 3.1, 9.0 Hz, 1 H), 6.23 (s, 1 H), 6.62 (d, J = 8.1 Hz, 1 H), 6.86 (td, J = 1.1, 7.3 Hz, 1 H), 6.97 (dd, J = 1.7, 7.3 Hz, 1 H), 7.02 (td, J = 1.6, 7.7 Hz, 1 H), 7.35-7.45 (m, 2 H), 7.50-7.60 (m, 1 H), 7.85-7.90 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 13.9, 22.3, 29.4, 32.5, 41.2, 74.2, 116.5, 118.8, 121.4, 122.5, 125.9, 128.3, 128.4, 128.5, 133.2, 137.1, 137.6, 150.7, 197.6. IR (CHCl₃): 1676 cm^-1. MS: m/z (%) = 306 (6.2) [M⁺], 187 (100), 157 (13.8). HRMS: m/z [M⁺] calcd for C₂₁H₂₂O₂: 306.1620; found: 306.1625.2-(3-Methyl-2-oxobutyl)-3-phenyl-2 H -1-benzopyran (6e): colorless needles (recrystallized from EtOAc-n-hexane); mp 75-77 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.00 (d, J = 7.0 Hz, 3 H), 1.05 (d, J = 7.0 Hz, 3 H), 2.28 (dd, J = 2.2, 16.2 Hz, 1 H), 2.51 (septet, J = 7.0 Hz, 1 H), 3.23 (dd, J = 10.0, 16.2 Hz, 1 H), 6.02 (dd, J = 2.2, 9.9 Hz, 1 H), 6.80 (d, J = 7.2 Hz, 1 H), 6.82 (s, 1 H), 6.92 (td, J = 1.0, 7.4 Hz, 1 H), 7.09-7.16 (m, 2 H), 7.28-7.41 (m, 3 H), 7.49-7.53 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 17.6, 17.7, 41.8, 42.8, 72.6, 116.6, 119.7, 121.7, 122.5, 125.3, 126.9, 128.2, 128.9, 129.4, 134.6, 136.0, 150.9, 212.4. IR (CHCl₃): 1703, 1594 cm^-1. MS: m/z (%) = 292 (7.9) [M⁺], 207 (100), 178 (12.8). HRMS: m/z [M⁺] calcd for C₂₀H₂₀O₂: 292.1463; found: 292.1464. Anal. Calcd for C₂₀H₂₀O₂: C, 82.34; H, 6.89. Found: C, 82.34; H, 6.66.5-Methoxy-3-phenyl-2-(2-phenyl-2-oxoethyl)-2 H -1-benzopyran (6f): yellowish oil. ¹H NMR (300 MHz, CDCl₃): δ = 2.76 (dd, J = 2.2, 16.5 Hz, 1 H), 3.83 (dd, J = 9.7, 16.3 Hz, 1 H), 3.89 (s, 3 H), 6.17 (dd, J = 2.2, 9.6 Hz, 1 H), 6.38 (d, J = 8.3 Hz, 1 H), 6.49 (d, J = 7.7 Hz, 1 H), 7.04 (t, J = 8.3 Hz, 1 H), 7.22-7.33 (m, 2 H), 7.35-7.42 (m, 3 H), 7.38 (s, 1 H), 7.48-7.55 (m, 1 H), 7.55-7.60 (m, 2 H), 7.80-7.86 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 40.7, 55.7, 72.1, 103.6, 109.9, 111.9, 114.5, 125.3, 127.9, 128.3, 128.5, 128.8, 129.3, 132.5, 133.2, 136.3, 137.0, 151.6, 155.5, 197.4. IR (CHCl₃): 1680, 1594 cm^-1. MS: m/z (%) = 356 (5.9) [M⁺], 237 (100), 222 (11.7). HRMS: m/z [M⁺] calcd for C₂₄H₂₀O₃: 356.1412; found: 356.1410.Methyl (5-Methoxy-3-phenyl-2 H -1-benzopyran-2-yl)acetate (6g): colorless oil. ¹H NMR (300 MHz, CDCl₃): δ = 2.45 (dd, J = 2.9, 15.2 Hz, 1 H), 2.89 (dd, J = 10.1, 15.2 Hz, 1 H), 3.67 (s, 3 H), 3.86 (s, 3 H), 5.86 (dd, J = 2.9, 10.1 Hz, 1 H), 6.49 (d, J = 8.3 Hz, 1 H), 6.53 (d, J = 8.1 Hz, 1 H), 7.10 (t, J = 8.3 Hz, 1 H), 7.21 (s, 1 H), 7.24-7.35 (m, 1 H), 7.35-7.40 (m, 2 H), 7.50-7.60 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 37.8, 51.8, 55.7, 72.6, 103.8, 109.8, 111.8, 114.8, 125.3, 127.9, 128.8, 129.5, 132.0, 136.4, 151.4, 155.6, 170.9. IR (CHCl₃): 1726, 1593 cm^-1. MS: m/z (%) = 310 (10.8) [M⁺], 237 (100), 222 (15.6). HRMS: m/z [M⁺] calcd for C₁₉H₁₈O₄: 310.1205; found: 310.1201.Ethyl (5,7-Dimethoxy-3-phenyl-2 H -1-benzopyran-2-yl)acetate (6h): colorless oil. ¹H NMR (300 MHz, CDCl₃): δ = 1.25 (t, J = 7.2 Hz, 3 H), 2.44 (dd, J = 2.9, 15.4 Hz, 1 H), 2.88 (dd, J = 10.3, 15.4 Hz, 1 H), 3.78 (s, 3 H), 3.84 (s, 3 H), 4.06-4.23 (m, 2 H), 5.85 (dd, J = 2.9, 9.9 Hz, 1 H), 6.08 (d, J = 2.2 Hz, 1 H), 6.10 (d, J = 2.2 Hz, 1 H), 7.13 (s, 1 H), 7.23-7.28 (m, 1 H), 7.34-7.39 (m, 2 H), 7.50-7.52 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 14.2, 37.9, 55.4, 55.6, 60.7, 73.0, 92.3, 94.3, 105.3, 114.7, 124.9, 127.4, 128.8 (2), 136.6, 152.6, 156.5, 161.5, 170.6. IR (CHCl₃): 1721, 1608 cm^-1. MS: m/z (%) = 354 (11.2) [M⁺], 267 (100). HRMS: m/z [M⁺] calcd for C₂₁H₂₂O₅: 354.1467; found: 354.1459.Methyl (3-Phenyl-5-trimethylsilyl-2 H -1-benzopyran-2-yl)acetate (6i): colorless oil. ¹H NMR (300 MHz, CDCl₃): δ = 0.26 (s, 9 H), 2.47 (dd, J = 2.8, 16.1 Hz, 1 H), 2.92 (dd, J = 9.2, 16.1 Hz, 1 H), 3.61 (s, 3 H), 6.06 (dd, J = 2.8, 9.2 Hz, 1 H), 6.78 (s, 1 H), 6.92 (t, J = 7.3 Hz, 1 H), 7.11 (dd, J = 1.5, 7.3 Hz, 1 H), 7.25 (dd, J = 1.8, 7.3 Hz, 1 H), 7.28-7.35 (m, 1 H), 7.35-7.43 (m, 2 H), 7.48-7.55 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = -0.95, 38.1, 51.7, 73.0, 120.6, 121.0, 121.3, 125.4, 126.7, 128.1, 128.4, 128.9, 133.3, 135.1, 136.3, 155.8, 170.9. IR (CHCl₃): 1727, 1589 cm^-1. MS: m/z (%) = 352 (8.1) [M⁺], 279 (100). HRMS: m/z [M⁺] calcd for C₂₁H₂₄O₃Si: 352.1495; found: 352.1496.2-(2-Oxopropyl)-3-phenyl-5-trimethylsilyl-2 H -1-benzopyran (6j): colorless oil. ¹H NMR (300 MHz, CDCl₃): δ = 0.24 (s, 9 H), 2.09 (s, 3 H), 2.40 (dd, J = 2.1, 17.8 Hz, 1 H), 3.21 (dd, J = 9.0, 17.8 Hz, 1 H), 6.17 (dd, J = 2.0, 9.0 Hz, 1 H), 6.77 (s, 1 H), 6.92 (t, J = 7.2 Hz, 1 H), 7.10 (dd, J = 1.7, 7.3 Hz, 1 H), 7.24 (dd, J = 1.7, 7.3 Hz, 1 H), 7.26-7.33 (m, 1 H), 7.34-7.42 (m, 2 H), 7.44-7.52 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = -0.94, 30.6, 46.4, 71.1, 120.2, 121.1, 121.3, 125.2, 126.8, 128.1, 128.4, 128.9, 133.8, 135.0, 136.1, 155.8, 205.1. IR (CHCl₃): 1714, 1579 cm^-1. MS: m/z (%) = 336 (8.4) [M⁺], 279 (100). HRMS: m/z [M⁺] calcd for C₂₁H₂₄O₂Si: 336.1546; found: 336.1545.3-Butyl-2-(2-phenyl-2-oxoethyl)-5-trimethylsilyl-2 H -1-benzopyran (6k): yellowish oil. ¹H NMR (300 MHz, CDCl₃): δ = 0.10 (s, 9 H), 0.92 (t, J = 7.2 Hz, 3 H), 1.33-1.41 (m, 2 H), 1.48-1.59 (m, 2 H), 2.08 (t, J = 7.7 Hz, 2 H), 2.95 (dd, J = 3.4, 17.0 Hz, 1 H), 3.63 (dd, J = 8.2, 17.1 Hz, 1 H), 5.59 (dd, J = 3.3, 8.3 Hz, 1 H), 6.19 (s, 1 H), 6.85 (t, J = 7.2 Hz, 1 H), 6.97 (dd, J = 1.7, 7.3 Hz, 1 H), 7.13 (dd, J = 1.7, 7.2 Hz, 1 H), 7.37-7.44 (m, 2 H), 7.51-7.53 (m, 1 H), 7.87-7.91 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = -0.93, 13.9, 22.4, 29.3, 32.5, 41.5, 73.1, 119.0, 120.9, 121.4, 126.5, 127.3, 128.2, 128.5, 133.2, 133.9, 137.0, 137.1, 155.7, 197.1. IR (CHCl₃): 1682, 1594 cm^-1. MS: m/z (%) = 378 (5.18) [M⁺], 260 (23.7), 259 (100). HRMS: m/z [M⁺] calcd for C₂₄H₃₀O₂Si: 378.2015; found: 378.2013.2-Phenyl-(2-phenyl-2-oxoethyl)-3 H -naphtho[2,1- b ]pyran (6l): yellowish oil. ¹H NMR (300 MHz, CDCl₃): δ = 2.79 (dd, J = 2.2, 16.3 Hz, 1 H), 3.93 (dd, J = 9.8, 16.3 Hz, 1 H), 6.29 (dd, J = 2.1, 9.6 Hz, 1 H), 6.97 (d, J = 8.8 Hz, 1 H), 7.30-7.70 (m, 12 H), 7.75-7.85 (m, 3 H), 8.13 (d, J = 8.6 Hz, 1 H). ¹³C NMR (75 MHz, CDCl₃): δ = 40.3, 72.8, 115.2, 115.8, 118.4, 121.3, 123.9, 125.4, 126.8, 128.2, 128.3, 128.5, 128.7, 129.0, 129.6, 129.8, 123.0, 133.1, 133.2, 136.4, 137.0, 149.0, 197.3. IR (CHCl₃): 1721, 1600 cm^-1. MS: m/z (%) = 376 (6.4) [M⁺], 257 (100), 228 (7.0). HRMS: m/z [M⁺] calcd for C₂₇H₂₀O₂: 376.1463; found: 376.1457.